Cardinal Health Inc (CAH)
Immuron Limited (IMRN)
908 Devices Inc (MASS)
Novavax Inc (NVAX)
Novavax Announces Entering into a License Agreement with Pfizer
RAPT Therapeutics Inc (RAPT)
Corvus Pharmaceuticals Inc (CRVS)
CAN FITE BIO (CANF)
Cidara Therapeutics Inc. (CDTX)
NervGen Pharma Corp. (NGENF)
NervGen Pharma to Ring the Nasdaq Closing Bell on January 22, 2026, Celebrating Its Recent Nasdaq Listing
Mind Medicine (MNMD)
Definium Therapeutics Introduces Rerouting Minds, an Educational Campaign Exploring the Potential of Pharmaceutical Lysergide (LSD) in Me...
CAN FITE BIO (CANF)
Can-Fite Completes Patient Enrollment in Phase 2a Pancreatic Cancer Study of Namodenoson
BioXcel Therapeutics Inc. (BTAI)
AIM ImmunoTech Inc. (AIM)
908 Devices Inc (MASS)
908 Devices Inc. - 908 Devices Announces Strong Preliminary Financial Results for Fourth Quarter and Full Year 2025